T1	Chemical	0 17	Both chemotherapy
T2	Gene_or_protein	22 54	epidermal growth factor receptor
T3	Chemical	22 81	epidermal growth factor receptor tyrosine kinase inhibitors
T4	Gene_or_protein	84 91	EGFR TK
T5	Chemical	84 99	EGFR TKIs ) are
T6	Disease	136 178	non-small cell lung cancer ( NSCLC ) , but
T7	Pharmacodynamic_phenotype	183 200	efficacy of these
R1	influences	Arg1:T1	Arg2:T2
R2	influences	Arg1:T1	Arg2:T3
R3	influences	Arg1:T1	Arg2:T4
R4	influences	Arg1:T1	Arg2:T5
R5	treats	Arg1:T1	Arg2:T6
R6	treats	Arg1:T1	Arg2:T7
R7	influences	Arg1:T2	Arg2:T1
R8	influences	Arg1:T2	Arg2:T3
R9	influences	Arg1:T2	Arg2:T4
R10	influences	Arg1:T2	Arg2:T5
R11	treats	Arg1:T2	Arg2:T6
R12	treats	Arg1:T2	Arg2:T7
R13	influences	Arg1:T3	Arg2:T1
R14	influences	Arg1:T3	Arg2:T2
R15	isEquivalentTo	Arg1:T3	Arg2:T4
R16	isEquivalentTo	Arg1:T3	Arg2:T5
R17	treats	Arg1:T3	Arg2:T6
R18	treats	Arg1:T3	Arg2:T7
R19	influences	Arg1:T4	Arg2:T1
R20	isEquivalentTo	Arg1:T4	Arg2:T2
R21	isEquivalentTo	Arg1:T4	Arg2:T3
R22	isEquivalentTo	Arg1:T4	Arg2:T5
R23	treats	Arg1:T4	Arg2:T6
R24	influences	Arg1:T4	Arg2:T7
R25	influences	Arg1:T5	Arg2:T1
R26	isEquivalentTo	Arg1:T5	Arg2:T2
R27	isEquivalentTo	Arg1:T5	Arg2:T3
R28	isEquivalentTo	Arg1:T5	Arg2:T4
R29	treats	Arg1:T5	Arg2:T6
R30	treats	Arg1:T5	Arg2:T7
R31	influences	Arg1:T6	Arg2:T1
R32	influences	Arg1:T6	Arg2:T2
R33	influences	Arg1:T6	Arg2:T3
R34	influences	Arg1:T6	Arg2:T4
R35	influences	Arg1:T6	Arg2:T5
R36	influences	Arg1:T6	Arg2:T7
R37	influences	Arg1:T7	Arg2:T1
R38	influences	Arg1:T7	Arg2:T2
R39	influences	Arg1:T7	Arg2:T3
R40	influences	Arg1:T7	Arg2:T4
R41	influences	Arg1:T7	Arg2:T5
R42	treats	Arg1:T7	Arg2:T6
